IGM Biosciences's total assets for Q4 2024 were $265.71M, a decrease of -12.74% from the previous quarter. IGMS total liabilities were $217.54M for the fiscal quarter, a -3.56% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.